Die selbstständige Blutzuckerkontrolle ist für viele Patienten mit Diabetes mellitus
heute ein fester Bestandteil des Krankheitsmanagements. Eine kontinuierliche interstitielle
Glukosemessung ermöglicht eine weitere Verbesserung der Dosisanpassung bei Patienten
unter intensivierter konventioneller Insulinbehandlung und bei Patienten mit Insulinpumpen.
Abstract
Today, self-measurement of glucose concentrations represents an integral part in disease
management for many patients with diabetes mellitus. Starting with urine glucose test
stripes about 50 years ago, patients were enabled to perform measurements of glucose
control by their own. Proceeding from urine glucose measurements to capillary blood
glucose in the 1960ies provided totally new opportunities and created the basis for
modern intensified insulin treatment with an adaptation of insulin dosages according
to actual blood glucose concentrations. Today, we are moving from punctual capillary
blood glucose measurements to continuous measurement of glucose concentrations in
the interstitial fluid. Again, opening a new century of glucose control for patients
with diabetes mellitus. The opportunity of continuous glucose monitoring allows further
improvement in insulin dose adaptation in patients on intensified conventional insulin
treatment and those on insulin pumps. Connecting continuous glucose sensors with insulin
pumps allow for continuous adaptation of insulin supply based on actual glucose readings
and might pave the way to an artificial pancreas. With all these progress in glucose
sensing technologies, it is still essential to teach the patients about the meaning
of their glucose readings, and to draw adequate therapeutical conclusions.
Schlüsselwörter
Glukosemessung - Uringlukose - Blutglukose - interstitielle Glukose - Glukosekontrollierte
Insulintherapie
Keywords
glucose measurement - urinary glucose - blood glucose - interstitial glucose - glucose-controlled
insulin treatment
